Tryp Therapeutics Future Growth
Future criteria checks 3/6
Tryp Therapeutics is forecast to grow earnings and revenue by 71.6% and 115.8% per annum respectively while EPS is expected to grow by 69.6% per annum.
Key information
71.6%
Earnings growth rate
69.6%
EPS growth rate
Pharmaceuticals earnings growth | 71.2% |
Revenue growth rate | 115.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Dec 2023 |
Recent future growth updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
8/31/2026 | N/A | -6 | N/A | N/A | 1 |
8/31/2025 | N/A | -6 | N/A | N/A | 1 |
8/31/2024 | N/A | -5 | N/A | N/A | 1 |
2/29/2024 | N/A | -3 | -6 | -6 | N/A |
11/30/2023 | N/A | -5 | -4 | -4 | N/A |
8/31/2023 | N/A | -5 | -4 | -4 | N/A |
5/31/2023 | N/A | -6 | -4 | -4 | N/A |
2/28/2023 | N/A | -6 | -4 | -4 | N/A |
11/30/2022 | N/A | -6 | -5 | -5 | N/A |
8/31/2022 | N/A | -7 | -6 | -6 | N/A |
5/31/2022 | N/A | -8 | -7 | -7 | N/A |
2/28/2022 | N/A | -10 | -8 | -7 | N/A |
11/30/2021 | N/A | -11 | -7 | -7 | N/A |
8/31/2021 | N/A | -8 | -5 | -5 | N/A |
5/31/2021 | N/A | -6 | -3 | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: TRYP is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.1%).
Earnings vs Market: TRYP is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: TRYP is expected to become profitable in the next 3 years.
Revenue vs Market: TRYP is forecast to have no revenue next year.
High Growth Revenue: TRYP is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if TRYP's Return on Equity is forecast to be high in 3 years time